XML 80 R38.htm IDEA: XBRL DOCUMENT v3.22.2.2
Income Tax (Tables)
12 Months Ended
Dec. 31, 2021
Income Taxes [Abstract]  
Summary of Current and Deferred Tax Expense

The following table illustrates the current and deferred taxes for the periods indicated:

 

 

 

Years ended
December 31,

(in millions)

 

2021

 

2020

 

2019

Current income taxes

 

4,535.0

 

 

€(0.2)

Deferred taxes

 

218.9

 

  (161.0)

 

Income taxes

 

4,753.9

 

€(161.0)

 

€(0.2)

Summary of Reconciliation of Expected Income Tax Benefit to Actual Income Tax Benefit

The following table reconciles the expected income taxes to the actual current income taxes and deferred taxes as presented in the table above. The expected income taxes were calculated using the combined income tax rates of BioNTech SE applicable to the Group and mentioned above which was applied to profit before taxes to calculate the expected income taxes.

 

 

 

Years ended
December 31,

(in millions)

 

2021

 

2020(1)

 

2019(1)

Profit / (Loss) before tax

 

15,046.4

 

€(145.8)

 

€(179.4)

 

 

 

 

 

 

 

Expected tax credit / (benefit)

 

4,622.5

 

€(44.9)

 

€(55.2)

 

 

 

 

 

 

 

Effects

 

 

 

 

 

 

Deviation due to local tax basis

 

9.1

 

0.6

 

0.1

Deviation due to deviating income tax rate (Germany and foreign countries)

 

9.4

 

1.3

 

0.1

Change in valuation allowance

 

3.0

 

  (26.2)

 

  (0.2)

Effects from tax losses

 

19.5

 

  (90.4)

 

51.2

Change in deferred taxes due to tax rate change

 

  (7.5)

 

 

Non-deductible expenses

 

90.5

 

0.8

 

0.1

Tax-free income

 

  (0.3)

 

 

Non tax-effective share-based payment expenses

 

15.5

 

9.8

 

9.3

Tax-effective equity transaction costs

 

  (1.2)

 

  (10.2)

 

  (5.1)

Adjustment prior year taxes

 

  (2.9)

 

0.3

 

  (0.3)

Non-tax effective bargain purchase

 

  (0.7)

 

  (2.2)

 

Other effects

 

  (3.0)

 

0.1

 

  (0.2)

Income taxes

 

4,753.9

 

€(161.0)

 

€(0.2)

Effective tax rate

 

31.6%

 

n.m.(2)

 

n.m.(2)

 

(1)
Certain amounts have been combined in the prior period to conform with the current period presentation.
(2)
The information is not meaningful due to the loss before tax in the respective periods.
Summary of Deferred Taxes

Deferred taxes for the periods indicated relate to the following:

 

Year ended December 31, 2021

 

 

 

 

 

 

 

 

 

 

(in millions)

 

January 1,
2021

 

Recognized in P&L

 

Recognized in OCI

 

Acquisition of subsidiaries and
businesses

 

December 31,
2021

Fixed assets

 

5.6

 

€(1.3)

 

 

€(10.8)

 

€(6.5)

Right-of-use assets(1)

 

  (30.0)

 

  (17.5)

 

 

 

  (47.5)

Inventories

 

1.0

 

0.8

 

 

 

1.8

Trade and other receivables

 

  (3.0)

 

  (92.6)

 

 

 

  (95.6)

Lease liabilities(1)

 

25.4

 

23.3

 

 

 

48.7

Contract liabilities

 

23.4

 

  (12.8)

 

 

 

10.6

Loans and borrowings

 

0.5

 

22.6

 

 

 

23.1

Net employee defined benefit liabilities

 

0.8

 

0.1

 

 

 

0.9

Other provisions

 

1.5

 

4.8

 

 

 

6.3

Other (incl. deferred expenses)

 

10.6

 

  (9.0)

 

 

 

1.6

Tax losses / tax credits

 

175.7

 

  (106.8)

 

 

2.0

 

70.9

Deferred tax assets / (liabilities), net (before valuation adjustment)

 

211.5

 

€(188.4)

 

 

€(8.8)

 

14.3

Valuation adjustment

 

  (50.5)

 

  (30.5)

 

 

 

  (81.0)

Deferred tax assets / (liabilities), net (after valuation adjustment)

 

161.0

 

€(218.9)

 

 

€(8.8)

 

€(66.7)

 

Year ended December 31, 2020

 

 

 

 

 

 

 

 

 

 

(in millions)

 

January 1,
2020

 

Recognized in P&L(2)

 

Recognized in OCI

 

Acquisition of subsidiaries and
businesses

 

December 31,
2020

Fixed assets

 

€(0.7)

 

€(2.4)

 

 

8.7

 

5.6

Right-of-use assets(1)

 

  (16.9)

 

  (3.4)

 

 

  (9.7)

 

  (30.0)

Inventories

 

0.6

 

 

 

0.4

 

1.0

Trade and other receivables

 

 

  (3.0)

 

 

 

  (3.0)

Lease liabilities(1)

 

17.4

 

  (1.7)

 

 

9.7

 

25.4

Loans and borrowings

 

 

0.3

 

 

0.2

 

0.5

Contract liabilities

 

23.5

 

  (0.1)

 

 

 

23.4

Net employee defined benefit liabilities

 

 

0.2

 

  (0.1)

 

0.7

 

0.8

Other provisions

 

0.2

 

0.9

 

 

0.4

 

1.5

Other (incl. deferred expenses)

 

2.1

 

8.3

 

 

0.2

 

10.6

Tax losses / tax credits

 

109.8

 

41.6

 

 

24.3

 

175.7

Deferred tax assets net (before valuation adjustment)

 

136.0

 

40.7

 

€(0.1)

 

34.9

 

211.5

Valuation adjustment

 

  (136.0)

 

120.3

 

 

  (34.8)

 

  (50.5)

Deferred tax assets net (after valuation adjustment)

 

 

161.0

 

€(0.1)

 

0.1

 

161.0

 

(1)
Presentation has been adjusted to present right-of-use assets and lease liabilities as well as trade and other receivables separately.
(2)
Includes all changes in deferred taxes related to U.S. tax group other than those acquired in business combination.
Summary of Accumulated Tax Losses Up until the year ended December 31, 2020, our accumulated tax losses

comprised also those of the German tax group. Our accumulated tax losses for the periods indicated amounted to the following:

 

 

 

Years ended
December 31,

(in millions)

 

2021

 

2020

 

2019

Corporate tax

 

272.0

 

596.4

 

356.0

Trade tax

 

170.6

 

513.6

 

352.3

 

 

 

Years ended
December 31,

(in millions)

 

2021

 

2020

 

2019

Federal tax credits

 

4.0

 

0.8

 

State tax credits

 

1.6

 

0.3